HER2-Positive Breast Cancer Patients Needed For Study In Houston

    Comments: 0  | Leave A Comment

    via: news92fm.com

    Patients who have been diagnosed with HER2-positive breast cancer may be eligible for a clinical study led by Baylor College of Medicine. The multi-institutional research will evaluate a new method of treatment that combines HER2-targeted therapies and excludes chemotherapy.

    The study is a follow-up to a recent clinical trial that showed HER2-positive breast cancer patients using trastuzumab (Herceptin) and lapatinib (Tykerb) for 12 weeks – without chemotherapy. Patients reportedly showed a significant benefit in the eradication of breast cancer tumors. The data was released in May 2011 by the

    Read More

    Join the Conversation! Share and Discuss!

    Tags: » » » » »

    Comments

    Follow

    Get every new post delivered to your Inbox.

    Join 1,450 other followers